中国内地一剂含腮腺炎疫苗对野生型F基因型腮腺炎病毒的效力评估
该研究分析2001至2015年中国内地F基因型腮腺炎病毒代表株的HN基因序列及139对免疫前后血清,发现一剂含腮腺炎疫苗诱导的中和抗体滴度普遍较低,且疫苗株与野生株间存在显著中和滴度差异;一剂疫苗有交叉保护但效力有限,作者建议为学龄前儿童提供第二剂疫苗。
要点
- 一剂含腮腺炎疫苗对野生型F基因型腮腺炎病毒有交叉保护作用,但效力有限。
- 疫苗株与野生株在潜在抗原表位存在基因型特异性氨基酸变异。
- 腮腺炎特异性IgG浓度与中和抗体滴度线性相关性差。
核心结论
- 一剂含腮腺炎疫苗对野生型F基因型腮腺炎病毒有交叉保护作用,但效力有限,可能由疫苗剂量不足及疫苗株与野生株间基因型特异性抗原差异所致。
研究设计与样本
- 研究分析2001至2015年中国内地70株F基因型腮腺炎病毒代表株的HN基因序列、两型疫苗株及139对婴儿接种一剂含腮腺炎疫苗前后的血清样本。
主要发现
- 疫苗株与野生型F基因型腮腺炎病毒在潜在抗原表位存在基因型特异性氨基酸变异。
- 一剂含腮腺炎疫苗诱导的腮腺炎中和抗体滴度普遍较低。
- 疫苗株与野生株间中和滴度存在显著差异。
- 腮腺炎特异性IgG浓度与中和抗体滴度呈差的线性相关,提示IgG浓度不能完全反映血清中和抗体滴度。
临床怎么用
- 作者强烈建议为学龄前儿童提供第二剂含腮腺炎疫苗以提高腮腺炎病毒中和抗体滴度。
- 作者建议使用腮腺炎病毒交叉中和试验作为评估含腮腺炎疫苗对野生型腮腺炎病毒效力的首选工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To clarify the protective effect of one-dose mumps-containing vaccines (MuCV) in mainland China, the antigenic variations of HN gene and cross-neutralization capacities between MuCV and wild type genotype F MuVs were studied. In total, 70 HN gene sequences of genotype F MuV representative strains obtained from 2001 to 2015, two types of MuCV strains, 139 pairs of pre- and post-vaccination serum samples from infants receiving one dose of MuCV vaccination were analyzed. Genotype-specific amino acid variations were observed in the potential antigenic epitopes between MuCV and wild-type genotype F MuVs circulating in mainland China. The mumps neutralization antibody titers induced by one-dose MuCV were found to be generally low. Moreover, significant differences in neutralization titers were observed between vaccine and wild-type strains. It could be concluded that one-dose MuCV had a cross-protective effect against the wild-type genotype F MuVs, but its effectiveness was limited, which might be caused by insufficient doses of MuCV vaccination and the genotype-specific antigenic differences between vaccine and wild-type MuVs as well. In addition, a poor linear correlation between mumps-specific IgG concentrations and neutralization titers was observed in this study, indicating the concentration of MuV-specific IgG could not fully reflect the neutralizing antibody titer in serum. Therefore, it is highly recommended to provide a second dose of MuCV to preschool children to increase MuV neutralizing antibody titers and use MuV cross-neutralization test as preferred tool for assessment of mumps-containing vaccine effectiveness on wild-type MuVs. This is the first report to assess the effectiveness of one-dose Chinese MuCV against wild-type genotype F MuVs, which would be benefit for the development of mumps vaccination strategy.
引用
- Cui A, Zhu Z, Mao N, et al. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China. Vaccine. 2018. PMID: 30122648. doi:10.1016/j.vaccine.2018.08.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。